Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
147 hedge funds and large institutions have $400M invested in Intercept Pharmaceuticals, Inc. in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 36 increasing their positions, 47 reducing their positions, and 25 closing their positions.
32% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 25
21% more capital invested
Capital invested by funds: $331M → $400M (+$69M)
6% more funds holding
Funds holding: 139 → 147 (+8)
10% less call options, than puts
Call options by funds: $25.3M | Put options by funds: $28M
23% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$20.8M |
| 2 |
Millennium Management
New York
|
+$9.43M |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$5.52M |
| 4 |
HP
HealthInvest Partners
Stockholm,
Sweden
|
+$3.08M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$14.5M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$3.73M |
| 3 |
EAM
EULAV Asset Management
Sarasota,
Florida
|
-$3.54M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.11M |
| 5 |
BlackRock
New York
|
-$2.21M |
ICPT Hedge Fund Activity: Q4 2021 in Review
147 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2021, worth a combined $400M — up 21% from $331M a quarter earlier.
Buyers outnumbered sellers: 33 funds opened new ICPT positions and 25 closed out — a net gain of 8 holders — while 36 added to existing stakes and 47 trimmed.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $20.8M. The largest seller was Vanguard Group, cutting an estimated $14.5M.
- 147 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2021, up from 139 in Q3 2021.
- Funds reported $400M of Intercept Pharmaceuticals, Inc. stock for Q4 2021, up 21% quarter-over-quarter.
- 33 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2021 and 25 closed out, a net change of +8 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q4 2021 was Adage Capital Partners, an estimated $20.8M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q4 2021 was Vanguard Group, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2021.